Discontinuation report MIDAZOLAM INJECTION

Last updated on 2020-10-08 History
Report ID 125896
Drug Identification Number 02423766
Brand name MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM INJECTION
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MIDAZOLAM
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1mL and 10mL ampoules
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-10-07
Remaining supply date 2020-10-07
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-10-08 English Compare
v2 2020-10-07 French Compare
v1 2020-10-07 English Compare

Showing 1 to 3 of 3